Keyphrases
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Postoperative Mortality
70%
Postoperative Complications
43%
Emergency Department
36%
Anastomotic Leak
33%
Preoperative Risk Assessment
33%
Risk Stratification
33%
Right Colectomy
33%
Cluster Randomized Trial
33%
Prognostic Biomarker
33%
Triage
33%
Acute Care Surgery
33%
Medical Patients
33%
Right Hemicolectomy
19%
Acutely Admitted Patients
17%
Hazard Ratio
15%
Cluster Period
14%
Mortality Rate
14%
30-day Mortality
14%
American Society of Anesthesiologists Classification
13%
American Society of Anesthesiologists
13%
Confidence Interval
13%
Cox Regression Analysis
11%
Mortality Prediction
10%
Increased Mortality
9%
Non-invasive Biomarkers
9%
Multivariable
9%
Timing of Surgery
9%
Colon Cancer
9%
Morbidity Rate
9%
Intervention Group
9%
Denmark
8%
Index Admission
8%
Registry-based
8%
Elective Surgery
8%
National Registry
7%
Clinical High Risk
6%
Medicine and Dentistry
Urokinase Receptor
100%
Surgical Mortality
70%
Postoperative Complication
46%
Biological Marker
41%
Emergency Department
36%
Risk Stratification
33%
Malignant Neoplasm
33%
Colectomy
33%
Anastomosis Leakage
33%
Randomized Clinical Trial
33%
Anesthesiologist
30%
Hazard Ratio
20%
Hemicolectomy
19%
Proportional Hazards Model
17%
Mortality Rate
14%
All Cause Mortality
14%
Logistic Regression Analysis
12%
Cohort Analysis
9%
Morbidity
9%
Surgical Anastomosis
9%
Colon Cancer
9%
